Featured Story | By Kyle LaHucik Zosano Pharma laid off eight R&D workers in the weeks following the FDA's decision to not review the biotech's second attempt at getting its migraine patch approved. The company is exploring strategic alternatives as it has little left to dream about. read more |
| |
|---|
|
Top Stories By Kyle LaHucik Protalix BioTherapeutics intends to resubmit its once-rejected Fabry disease drug to the FDA in the second half of this year thanks to new phase 3 data, with more on the way in the coming weeks, a company spokesperson told Fierce Biotech. read more By Nick Paul Taylor Apexigen is braving a tough biotech stock market in a bid to land on the Nasdaq through a SPAC merger. If the deal goes through as planned, Apexigen will emerge with $73 million to fund development of a CD40 agonist intended to treat melanoma and other solid tumors. read more By Nick Paul Taylor Onconova Therapeutics’ early-phase development program for the multikinase inhibitor narazaciclib has cleared a small milestone, with the lack of dose-limiting toxicities in solid tumor patients in the original cohorts emboldening the biotech to plan to file a protocol amendment to study higher doses. read more By Max Bayer Summit Therapeutics believes the future of its lead asset to treat C. difficile may be through partnerships, months after the candidate failed to outperform vancomycin in a phase 3 trial. It hopes to present more data in May. The blueprint from the company comes after its shares have plummeted 50% in the last six months. read more By Kevin Dunleavy The United Nations-backed Medicines Patent Pool revealed that 35 companies have signed on to produce a generic version of Pfizer's oral antiviral COVID-19 treatment Paxlovid. The deal includes companies from 12 countries that will provide the drug to 95 lower- and middle-income countries. read more By Andrea Park The study focused specifically on African-American patients, who are vastly underrepresented in Alzheimer’s research and, on average, have limited access to comprehensive screening resources, but have a disproportionately high risk of developing the disease. read more By Kevin Dunleavy After a year in which its revenues declined by 6%, Teva has cut the pay of its top executives, including CEO Kare Schultz, who saw a drop in his compensation from $15.72 million in 2020 to $14.68 million, a 6.6% decrease. read more By Robert King The House Progressive Caucus wants CMS to get rid of the newly launched ACO REACH model, which is a rebrand of the controversial Direct Contracting Model that was overhauled after concerns from progressive lawmakers. read more By Angus Liu Eisai decided to exit its supporting role in Aduhelm. Chinese companies including several biotechs face potential U.S. delisting if they fail to comply with a new audit law. Zai Lab recruited Eli Lilly's former chief financial officer, who's leaving after a scandal. And more. read more By Max Bayer Camp4 Therapeutics has tapped Ann Barbier as CMO, the same role she held at Translate Bio before it was snatched up by Sanofi. Robert Hollingsworth is bidding farewell to big pharma life, leaving to be chief scientific officer of Shoreline Biosciences and oversee its early pipeline. Zai Lab is giving a second chance to former Eli Lilly CFO Josh Smiley a year after he resigned following an investigation into his conduct with colleagues. read more Resources Sponsored by: United Cargo The United Cargo team has made a commitment to pharmaceutical and medical partners that we are equipped to support their vaccine transportation needs safely and effectively across our expansive global and domestic network. The safety and security of these commodities is our priority, and we are proud to be a trusted partner in these efforts. Download infographic now. Sponsored by: H1 Read why many MSLs are still challenged in developing integrated strategies to increase the volume of meaningful engagements. Download this industry report to find out what the top challenges are and suggestion strategies to solve them. Download now. Sponsored by: Medidata, a Dassault Systèmes company The landscape of clinical trials has been permanently changed. Today's trials require sponsors to modernize their use of technology and data to adapt. This eBook provides an overview of how sponsors can empower trials with real-time performance data to improve study integrity, reduce risks, optimize patient safety, and increase trial success rates. Sponsored by: Thermo Fisher Scientific Learn how to navigate the top manufacturing challenges and achieve a seamless transition from discovery to clinical manufacturing across the CAR T-cell therapy workflow. Sponsored by: Oracle Health Sciences Learn about ways to break down regulatory roadblocks and get closer to 100% clarity on regulatory positions to advance decentralized clinical trials in research. Sponsored by: Oracle Health Sciences How to overcome top challenges faced in decentralized trials. Sponsored by: Catalent How can Lipid-Based Drug Delivery System help bring poorly soluble drugs to market? Sponsored by: Catalent Learn more about how the versatility of Softgel Technology helped a customer with a volatile compound. Sponsored by: Catalent What is the most suitable dosage form technology for the Oral Delivery of Lipid-Based Formulations? Sponsored by: Catalent Biologics Ypsomed and Catalent Biologics experts discuss strategies for integrated PFS manufacturing and auto-injector assembly to accelerate timelines and more in this webinar. Sponsored by: Catalent Biologics Learn how formulation development for a PFS affects manufacturing to drive the industry toward optimizing delivery of injectable products and, ultimately, improving patient care. Fierce BD&L Summit for Life Sciences March 15-16, 2022 | San Francisco, CA Fierce Promotional Review Committee Compliance and Best Practices Summit April 12-14, 2022 | New Brunswick, NJ Fierce Trial Master File Summit May 2-4, 2022 | New Orleans, LA & Streaming Live Fierce Digital Pharma Engage June 14-15, 2022 | Huntington Beach, CA Fierce Pharma PR & Communications Summit West June 14-15, 2022 | Huntington Beach, CA Fierce Digital Pharma Innovation Week June 21-23, 2022 | Virtual Event Fierce MedTech Summit August 8-9, 2022 | Minneapolis, MN Promotional Review Committee Compliance and Best Practices Summit West (PRC West) September 2022 | San Diego, CA Medical Affairs Strategic Summit (MASS West) September 2022 | San Diego, CA Fierce New Product Planning Summit September 20-22, 2022 | Boston, MA Fierce Digital Pharma East October 18-20, 2022 | Philadelphia, PA & October 25-28, 2022 | Virtual Event Fierce Pharma Marketing Awards October 19, 2022 | Philadelphia, PA Fierce Biotech Cell & Gene Therapy Forum October 19, 2022 | Virtual Event Fierce Pharma Meeting Professionals Summit November 2-3, 2022 | Atlantic City, NJ Fierce European Trial Master File Summit November 14-16, 2022 | London, UK Fierce Launch Readiness for Medical Affairs & Communications Teams Summit November 30-December 1, 2022 | Virtual Event Fierce JPM Week 2023 January 2023 | San Francisco, CA & Virtual | 
